- Home
- LZB vs ARWR Comparison
LZB vs ARWR Comparison
Compare LZB & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LZB
- ARWR
- Stock Information
- Founded
- LZB 1927
- ARWR 2003
- Country
- LZB United States
- ARWR United States
- Employees
- LZB N/A
- ARWR N/A
- Industry
- LZB Home Furnishings
- ARWR Biotechnology: Pharmaceutical Preparations
- Sector
- LZB Consumer Discretionary
- ARWR Health Care
- Exchange
- LZB Nasdaq
- ARWR Nasdaq
- Market Cap
- LZB 1.6B
- ARWR 1.7B
- IPO Year
- LZB N/A
- ARWR 1993
- Fundamental
- Price
- LZB $38.29
- ARWR $13.16
- Analyst Decision
- LZB Hold
- ARWR Buy
- Analyst Count
- LZB 1
- ARWR 11
- Target Price
- LZB N/A
- ARWR $41.44
- AVG Volume (30 Days)
- LZB 486.7K
- ARWR 2.2M
- Earning Date
- LZB 06-16-2025
- ARWR 05-08-2025
- Dividend Yield
- LZB 2.29%
- ARWR N/A
- EPS Growth
- LZB 7.87
- ARWR N/A
- EPS
- LZB 2.91
- ARWR N/A
- Revenue
- LZB $2,091,871,000.00
- ARWR $2,500,000.00
- Revenue This Year
- LZB $3.42
- ARWR $4,380.43
- Revenue Next Year
- LZB $3.50
- ARWR $64.24
- P/E Ratio
- LZB $13.17
- ARWR N/A
- Revenue Growth
- LZB 1.80
- ARWR N/A
- 52 Week Low
- LZB $32.00
- ARWR $9.57
- 52 Week High
- LZB $48.31
- ARWR $30.41
- Technical
- Relative Strength Index (RSI)
- LZB 47.87
- ARWR 49.87
- Support Level
- LZB $37.56
- ARWR $10.92
- Resistance Level
- LZB $39.81
- ARWR $13.45
- Average True Range (ATR)
- LZB 1.63
- ARWR 1.14
- MACD
- LZB 0.22
- ARWR 0.38
- Stochastic Oscillator
- LZB 71.71
- ARWR 90.21
About LZB La-Z-Boy Incorporated
La-Z-Boy Inc is a U.S.-based company that manufactures, distributes, and retails upholstery furniture products. It is a producer of reclining chairs and distributors of residential furniture in the U.S. The company chiefly operates in the United States but also has secondary operations in Canada and other countries. The company's reportable segments include the Wholesale segment, which manufactures and imports upholstered furniture; and Retail, which sells upholstered and case goods furniture to the end consumer. The majority of the company's revenue is derived from its Wholesale segment.
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.